Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 Jul:163:104763.
doi: 10.1016/j.ijmedinf.2022.104763. Epub 2022 Apr 15.

Improving morbidity information in Portugal: Evidence from data linkage of COVID-19 cases surveillance and mortality systems

Affiliations
Observational Study

Improving morbidity information in Portugal: Evidence from data linkage of COVID-19 cases surveillance and mortality systems

Rodrigo Feteira-Santos et al. Int J Med Inform. 2022 Jul.

Abstract

Background: COVID-19 rapidly spread around the world, putting health systems under unprecedented pressure and continuous adaptations. Well-established health information systems (HIS) are crucial in providing data to allow evidence-based policymaking and public health interventions in the pandemic response. This study aimed to compare morbidity information between two databases for COVID-19 management in Portugal and identify potential complementarities.

Methods: This is an observational study using records from both COVID-19 cases surveillance (National Epidemiological Surveillance System; SINAVE) and related deaths (National e-Death Certificates Information System; SICO) systems, which were matched on sex, age, municipality of residence and date of death. After the linkage, morbidity reported in SINAVE and identified in SICO, through the application of Charlson and Elixhauser comorbidity indexes algorithms, were compared to evaluate agreement level.

Results: Overall, 2285 matched cases were analyzed, including 53.9% males with a median age of 84 years. According to the method of data reporting assessment, the presence of any morbidity ranged between 26.3% and 62.5%. The reporting of ten morbidities could be compared between the information reported in SINAVE and SICO databases. The proportion of simultaneous reporting in both databases ranged between 5.7% for diabetes and 0.0% for human immunodeficiency virus infection or coagulopathy. Minimal or no agreement was found when assessing the similarity of the morbidity reporting in both databases, with neoplasms showing the highest level of agreement (0.352, 95% IC: 0.277-0.428; p < 0.001).

Conclusion: Different information about reported morbidity could be found in two HIS used to monitor COVID-19 cases and related deaths, as data are independently collected. These results show that the interoperability of SICO and SINAVE databases would potentially improve available HIS and improve available information to decision-making and address COVID-19 pandemic management.

Keywords: COVID-19; Health information system; Morbidity; Systems interoperability.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

None
Graphical abstract
Fig. 1
Fig. 1
Inclusion flow chart of records from SINAVE and SICO databases considered in the analysis (n = 2285) SICO, National e-Death Certificates Information System; SINAVE, National Epidemiological Surveillance System.
Fig. 2
Fig. 2
Workflow of data from SARS-CoV-2 infections and conceptual model integrated information systems. Footnotes: The red dashed arrows represent the actual information flow, continuous grey arrows the actual that is also considered the ideal flow and the blue dashed arrows the ideal proposed flow. SICO, National e-Death Certificates Information System; SINAVE, National Epidemiological Surveillance System. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

Similar articles

Cited by

References

    1. Zheng J. SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat. Int. J. Biol. Sci. 2020;16(10):1678–1685. doi: 10.7150/ijbs.45053. - DOI - PMC - PubMed
    1. World Health Organization (WHO), Coronavirus disease 2019 (COVID-19): situation report, 51, (2020). https://apps.who.int/iris/handle/10665/331475.
    1. Nader I.W., Zeilinger E.L., Jomar D., Zauchner C. Onset of effects of non-pharmaceutical interventions on COVID-19 infection rates in 176 countries. BMC Public Heal. 2021;211(21):1–7. doi: 10.1186/S12889-021-11530-0. - DOI - PMC - PubMed
    1. Negro-Calduch E., Azzopardi-Muscat N., Nitzan D., Pebody R., Jorgensen P., Novillo-Ortiz D. Health Information Systems in the COVID-19 Pandemic: A Short Survey of Experiences and Lessons Learned From the European Region. Front. Public Heal. 2021;9:1438. doi: 10.3389/FPUBH.2021.676838/BIBTEX. - DOI - PMC - PubMed
    1. Brailer D.J. Interoperability: the key to the future health care system. Health Aff. (Millwood). Suppl Web. 2005;24(Suppl1):W5-19–W5-21. - PubMed

Publication types